Tosoh Bioscience, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$554Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
454clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Sidney Clevinger | Ocala, FL | Family Medicine | $109,604.00 |
| Anthony Lyon | New York, NY | Family Medicine | $64,776.00 |
| Diana Gorokhovsky | Boynton Beach, FL | Family Medicine | $12,436.00 |
| Giselle Mery | Des Moines, IA | Medical Oncology | $10,812.00 |
| Bushra Ajaz | Orange City, FL | Hematology & Oncology | $10,812.00 |
| Gregory Ortega | Orange City, FL | Hematology & Oncology | $10,812.00 |
| Santosh Nair | Orange City, FL | Hematology & Oncology | $10,812.00 |
| Roderick Paras | Orange City, FL | Medical Oncology | $10,812.00 |
| Rene Cabeza | Orange City, FL | Hematology & Oncology | $10,812.00 |
| Bhanu Visvalingam | Orange City, FL | Medical Oncology | $10,812.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.